BioSpace News Archive

Drug Development

Neurotrope’s Alzheimer’s Drug Flunks Phase II Trial

Neurotrope announced that its Phase II trial of Bryostatin-1 in moderate to severe Alzheimer’s disease did not show statistical significance on the primary endpoint, change from baseline to Week 13 in the Severe Impairment Battery (SIB) total score.

September 9, 2019
·
3 min read
·
Mark Terry
Job Trends

Testing New Treatment for Epilepsy Patients

Seizure Onset Zone Located Immediately, Dealt With

September 9, 2019
·
2 min read
BioCapital

MaxCyte Announces Presentation at ICLE 2019

MaxCyte announces that Director of Field Applications Scientists Christopher Mann, PhD, will present on “Advancing Adoptive Cellular Therapies Using Non-viral-based Engineering” at the 2nd International Conference on Lymphocyte Engineering on Saturday 14 September at 9:50 a.m. BST.

September 9, 2019
·
1 min read
Sphere Fluidics introduces Cyto-Cellect Human IgGK Detection Kit

Sphere Fluidics introduced the Cyto-Cellect™ Human IgGK Detection Kit, to be used in conjunction with the Cyto-Mine® Single Cell Analysis System for rapid and cost-effective measurement of antibody class and productivity in cell line development.

September 9, 2019
·
2 min read
Drug Development

Alector Initiates Phase 2 Trial of AL001 in Patients with Frontotemporal Dementia

Alector, Inc., a clinical stage biotechnology company pioneering immuno-neurology, today announced the initiation of patient screening and enrollment for the INFRONT Phase 2 clinical trial for its product candidate AL001.

September 9, 2019
·
5 min read
Analysis Of Global Cancer Data Shines Light On Alternative Gene “Switches” In Tumours

Novel genomics and computational methods reveal how gene “switches” impact survival rates of cancer patients, paving the way to targeted cancer treatments

September 9, 2019
·
7 min read
Medigene Participates at Upcoming September 2019 Conferences

Martinsried/ Munich Medigene AG announced its participation at the following upcoming scientific and investor conferences.

September 9, 2019
·
1 min read
Business

What Makes BioMidwest a Great Place to Live?

The Midwestern region of the United States is often referred to as “flyover country” by residents of both coasts as a way to diminish or dismiss the importance of the states that make up this part of the nation. But the Midwest can be a great place to live and raise a family.

September 9, 2019
·
4 min read
·
Alex Keown
Drug Development

BerGenBio Presents Phase II Trial Updates with Selective AXL Inhibitor Bemcentinib in Non-Small Cell Lung Cancer at 2019 World Conference on Lung Cancer

BerGenBio ASA presents study updates from its Phase II clinical development programme with bemcentinib, a first-in-class highly selective oral AXL inhibitor, in non-small cell lung cancer at the 2019 World Conference on Lung Cancer in Barcelona, Spain.

September 9, 2019
·
5 min read
Business

SV Health Investors announces the appointment of Christian Jung, PhD as Partner in the Dementia Discovery Fund

Former Principal at Wellington Partners Life Sciences appointed to drive Fund’s European investments

September 9, 2019
·
4 min read